Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and COVID-19: The Clinical Course and Prognosis of 15 Patients From a Tertiary Care Center.


İnce B., Bektaş M., Koca N., Ağargün B. F., Zarali S., Güzey D. Y., ...Daha Fazla

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, cilt.28, sa.6, ss.300-304, 2022 (SCI-Expanded) identifier identifier identifier

Özet

Objective: The aim of this study was to evaluate incidence rates, prognoses, and disease-related factors associated with poor outcomes in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) who had coronavirus disease (COVID-19).